Cepheid Inc - Company Profile
Powered by 
All the data and insights you need on Cepheid Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Cepheid Inc Strategy Report
- Understand Cepheid Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Cepheid Inc (Cepheid), a subsidiary of Danaher Corp, is a molecular diagnostic company that develops, manufactures, and markets molecular systems and conducts tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care associated infections, critical infectious diseases, sexual health, virology, oncology and genetics; molecular diagnostic systems; and reagents and parts. Cepheid distributes its products directly and through a network of distributors present across the Americas, Asia, Europe, Africa and the Middle East. The company also offers various services such as maintenance, software updates, repair, and support among others. Cepheid is headquartered in Sunnyvale, California, the US.
Headquarters
United States of America
Address
904 Caribbean Drive, Sunnyvale, California, 94089
Website
www.cepheid.com
Telephone
1 888 8383222
Industry
Medical Equipment
Cepheid Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Healthcare Associated Infections: | Maintenance | Cepheid |
| Xpert MRSA NxG | Support | SmartCycler |
| Xpert MRSA/SA SSTI | Repair | GeneXpert |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In August, the company entered into an agreement with U.S. Army Health Contracting for SARS-CoV-2 and Streptococcus pyogenes testing. |
| 2023 | Regulatory Approval | In March, the company received a medical device license for Xpert, Xpress CoV-2plus from Health Canada. |
| 2023 | Regulatory Approval | In February, the company received Emergency Use Authorization (EUA) from the US Food and Drug Administration for Xpert Mpox. |
Competitor Comparison
| Key Parameters | Cepheid Inc | Hologic Inc | Meridian Bioscience Inc | GenMark Diagnostics Inc | Binx Health Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Sunnyvale | Marlborough | Cincinnati | Carlsbad | Cambridge |
| State/Province | California | Massachusetts | Ohio | California | Massachusetts |
| No. of Employees | - | 6,990 | - | - | - |
| Entity Type | Private | Public | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| David H. Persing | Chief Medical Officer; Chief Technology Officer; Director; Executive Vice President | Executive Board | 2005 | - |
| Vitor Rocha | President | Senior Management | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer